Abstracts Archive - Page 2059 of 2607 - ACR Meeting Abstracts

Abstract Number: 2619 • 2014 ACR/ARHP Annual Meeting
Low Socioeconomic Status (SES) As Measured By Education Is (not) Associated with Worse Outcome in SLE: Data from the 1000 Canadian Faces of Lupus
Angela George¹, Christine Peschken², Earl Silverman³, Christian A. Pineau⁴, C Douglas Smith⁵, Hector Arbillaga⁶, Michel Zummer⁷, Ann Clarke⁸, Sasha Bernatsky⁹, Marie Hudson¹⁰, Carol A. Hitchon¹¹, Paul R. Fortin¹² and Janet E. Pope¹³, ¹Medicine/Rheumatology, University of Western Ontario, London, ON, Canada, ²Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ³Pediatrics/Rheumatology, Toronto Hospital for Sick Children, U of Toronto, Toronto, ON, Canada, ⁴Rheumatology, McGill University Health Center, Montreal, QC, Canada, ⁵The Arthritis Centre, TOH Riverside Campus, Ottawa, ON, Canada, ⁶Medicine/Rheumatology, Lethbridge Rheumatology practice, Lethbridge, AB, Canada, ⁷Medicine/Rheumatology, U of Montreal, Montreal, QC, Canada, ⁸Medicine/Allergy, U of Calgary, Calgary, AB, Canada, ⁹Clinical Epidemiology, McGill UHC/RVH, Montreal, QC, Canada, ¹⁰Medicine/Rheumatology, McGill University, Montreal, QC, Canada, ¹¹Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ¹²Rheumatology, Laval University, Division of Rheumatology, Centre de Recherche du CHU de Québec and Department of Medicine, Quebec City, QC, Canada, ¹³St Joseph Health Care, London, ON, Canada
Background/Purpose: To determine whether socioeconomic status, as measured by education, impacts disease activity (measured by SLAM-2, SLEDAI-2K) or disease damage (measured by SLICC SDI) in…
Abstract Number: 2618 • 2014 ACR/ARHP Annual Meeting
Impact of Ustekinumab on Active Inflammation and Post-Inflammatory Structural Changes As Detected By Magnetic Resonance Imaging in Patients with Active Ankylosing Spondylitis: Results of a 28-Week, Prospective, Open-Label, Proof-of-Concept Study
Denis Poddubnyy¹, Kay-Geert Hermann¹, Johanna Callhoff², Joachim Listing² and Joachim Sieper¹, ¹Charité Universitätsmedizin Berlin, Berlin, Germany, ²German Rheumatism Research Center, Berlin, Germany
Background/Purpose Ustekinumab – a fully human monoclonal antibody against interleukins 12 and 23 – has been shown to be effective in reduction of symptoms of…
Abstract Number: 2617 • 2014 ACR/ARHP Annual Meeting
No Evidence of Accelerated Atheromatosis, Increased Arterial Stiffness or Hypertrophy in Ankylosing Spondylitis: A Systematic Case-Control Study
Aikaterini I. Arida¹, Maria Konsta¹, Alexios Iliopoulos², Maria Tektonidou³, George Konstantonis¹, George D. Kitas⁴, Athanasios D. Protogerou¹ and Petros P. Sfikakis¹, ¹First Department of Propedeutic Internal Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece, ²Department of Rheumatology, Veterans Administration Hospital, Athens, Greece, ³First Department of Internal Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece, ⁴The Dudley Group of Hospitals NHS Foundation Trust, Dudley, and Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom
Background/Purpose: Chronic inflammatory arthritis is associated with increased cardiovascular disease (CVD) risk. The mechanisms behind this link include chronic inflammation, comorbidities and disease-related drugs. CV…
Abstract Number: 2616 • 2014 ACR/ARHP Annual Meeting
Comparison of Characteristics of Ankylosing Spondylitis in Association with Familial Mediterranean Fever with Those of Typical Ankylosing Spondylitis
Dilek Solmaz¹, Servet Akar², Bunyamin Kisacik³, Sule Apras⁴, Soner Senel⁵, Ahmet Mesut Onat³, Timucin Kasifoglu⁶, Kenan Aksu⁷, Ismail Sari⁸, Mehmet Akif Ozturk⁹, Mehmet Sayarlioglu¹⁰, Ali Akdogan⁴, Pinar Cetin⁸ and Nurullah Akkoc⁸, ¹Department of Internal Medicine, Division of Rheumatology, Namik Kemal University School of Medicine, Tekirdag, Turkey, ²Department of Internal Medicine, Division of Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey, ³Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁴Rheumatology, HacettepeUniversity School of Medicine, Ankara, Turkey, ⁵Rheumatology, Kayseri Erciyes University School of Medicine, Kayseri, Turkey, ⁶Rheumatology, Eskisehir OsmangaziUniversity School of Medicine, Eskisehir, Turkey, ⁷Rheumatology, Ege University School of Medicine, Izmir, Turkey, ⁸Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey, ⁹Rheumatology, GaziUniversity School of Medicine, Ankara, Turkey, ¹⁰Rheumatology, KahramanmarasSutçü ImamUniversity School of Medicine, Kahramanmaras, Turkey
Background/Purpose Several case reports and a few published studies suggest a link between Familial Mediterranean Fever (FMF) and ankylosing spondylitis (AS). There is very limited…
Abstract Number: 2615 • 2014 ACR/ARHP Annual Meeting
Preliminary Assessment of a Multi-Biomarker Disease Activity Test for Axial Spondyloarthritis
Walter P. Maksymowych¹, Stephanie Wichuk¹, P. Scott Eastman² and Eric H. Sasso³, ¹Department of Medicine, University of Alberta, Edmonton, AB, Canada, ²Crescendo Bioscience, Inc., South San Francisco, CA, ³Crescendo Bioscience Inc., South San Francisco, CA
Background/Purpose There has been limited validation of soluble biomarker measures of disease activity in patients with axial spondyloarthritis (SpA). C-reactive protein (CRP) is most commonly…
Abstract Number: 2614 • 2014 ACR/ARHP Annual Meeting
Reliability of Electronic Patient Self-Assessment of Swollen and Tender Joints in Psoriatic Arthritis: A Comparison Study with B-Mode Ultrasonography, Physician and Nurse Assessments
Agnes Szentpetery¹, Muhammad Haroon², Eileen O'Flynn¹, Phil Gallagher¹, Shafeeq Alraqi¹ and Oliver FitzGerald¹, ¹Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, ²Newmarket On Fergus, Cork University Hospital, Cork, Ireland
Background/Purpose 68 tender (TJC) and 66 swollen joint counts (SJC) are recommended for disease activity assessment in psoriatic arthritis (PsA). However there are time constraints…
Abstract Number: 2633 • 2014 ACR/ARHP Annual Meeting
Factors Associated with Damage Accrual and Survival in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Prospective Cohort Analysis of 747 Patients
Chi Chiu Mok¹, Sau Mei Tse¹, Ling Yin Ho¹ and Chi Hung To², ¹Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, ²Flat D 20 /F Block 1, Chelsea Heights, Hong Kong, Hong Kong
Background/Purpose To evaluate the factors associated with accrual of organ damage in a longitudinal cohort of Chinese patients with SLEMethods A longitudinal cohort of 747…
Abstract Number: 2632 • 2014 ACR/ARHP Annual Meeting
The Cornerstone to Reasonable Allocation of Health Resource: Valuation of Health Utility in Systemic Lupus Erythematosus
Suli Wang and Liangjing Lu, Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Background/Purpose: In a time of increasing economic constraints, it is crucial that health systems optimize their resource use to ensure that they generate the maximum…
Abstract Number: 2631 • 2014 ACR/ARHP Annual Meeting
Overall Cause and Cause-Specific Mortality in a Multinational Inception Cohort of SLE
Murray B. Urowitz¹, Dafna D. Gladman¹, Nicole Anderson², Dominique Ibanez³ and Systemic Lupus International Collaborating Clinics (SLICC)⁴, ¹University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Rheumatology, Toronto Western Hospital Research Institute, Toronto, ON, Canada, ³Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴Toronto Western Hospital, Division of Rheumatology, University of Toronto, Toronto Western Hospital (Coordinating Center), Toronto, ON, Canada
Background/Purpose: A large multicenter multinational inception cohort was established initially to study risk factors for atherosclerosis (AS) in SLE. The aim of this study was…
Abstract Number: 2630 • 2014 ACR/ARHP Annual Meeting
An Evaluation of Quality of Life of Patients with Systemic Lupus Erythematosus Attending Rheumatology Clinic in Kenyatta National Hospital, Nairobi, Kenya
Jackline Odhiambo, internal medicine, university of nairobi, nairobi, Kenya
Background/Purpose Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that affects all organs of the body. Due to its chronicity SLE has been known…
Abstract Number: 2629 • 2014 ACR/ARHP Annual Meeting
Childhood-Onset and Adult-Onset Systemic Lupus Erythematosus: Distinctions in an Underserved Ethnic Minority Cohort
Rebekah Neal¹, Kimberly DeQuattro², Elizabeth C. Ortiz¹ and Francisco P. Quismorio Jr. ³, ¹Rheumatology, University of Southern California, Los Angeles, CA, ²LAC+USC Medical Center, Los Angeles, CA, ³Div of Rheum & Immun, Keck School of Medicine, University of Southern California, Los Angeles, CA
Background/Purpose: Previous studies suggest differences between childhood-onset SLE (cSLE) and adult onset SLE (aSLE). Whereas the prevalence of nephritis, neuropsychiatric, dermatologic, and hematologic manifestations are…
Abstract Number: 2628 • 2014 ACR/ARHP Annual Meeting
Risk of Cancer Is Not Increased in Patients with Cutaneous Lupus Erythematosus: A Population-Based Study
Abha G. Singh¹, Cynthia S. Crowson², Mark Davis³, Hilal Maradit Kremers², Eric L. Matteson¹ and Vaidehi Chowdhary⁴, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic, Rochester, MN, ³Dermatology, Mayo Clinic, Rochester, MN, ⁴Division of Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Systemic immune dysregulation associated with chronic autoimmune diseases such as systemic lupus erythematosus (SLE) as well as immunomodulatory medications used for their treatment have…
Abstract Number: 2627 • 2014 ACR/ARHP Annual Meeting
Comparison of Disease Characteristics and Organ Damage in Patients with Juvenile and Adult-Onset Systemic Lupus Erythematosus in Large Cohort from Turkey
Bahar Artim-Esen¹, Ozgur Kasapcopur², Sezgin Sahin³, Kenan Barut³, Ahmet Omma⁴, Yasemin Sahinkaya⁴, Sevil Kamali⁴, Lale Ocal⁴ and Murat Inanc⁴, ¹Department of Internal Medicine, Division of Rheumatology, Rheumatology Division, Department of Internal Medicine, Istanbul Faculty of Medicine,Istanbul University, Istanbul, Turkey, ²Department of Paediatrics, Division of Rheumatology, Rheumatology Division, Department of Paediatrics, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, TURKEY, Istanbul, Turkey, ³Rheumatology Division, Department of Paediatrics, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, TURKEY, Istanbul, Turkey, ⁴Rheumatology Division, Department of Internal Medicine, Istanbul Faculty of Medicine,Istanbul University, Istanbul, Turkey
Background/Purpose Systemic lupus erythematosus (SLE) is a multisystemic disease that may cause a broad spectrum of clinical and immunological manifestations. Age at onset has been…
Abstract Number: 2626 • 2014 ACR/ARHP Annual Meeting
Relationship of Socio-Demographic and Disease Factors with Loss-to-Follow-up and Appointment Noncompliance in Indigent Patients with Systemic Lupus Erythematosus
Angela Pham¹, Gaobin Bao², S. Sam Lim³ and Cristina Drenkard⁴, ¹Rheumatology, Emory University, Atlanta, GA, ²Medicine, Emory University, Atlanta, GA, ³Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ⁴Medicine, Div Rheumatology, Emory University, Atlanta, GA
Background/Purpose . The relationship of medical noncompliance with poor health outcomes has been described in chronic diseases, including systemic lupus erythematosus (SLE). These outcomes are…
Abstract Number: 2625 • 2014 ACR/ARHP Annual Meeting
Work Productivity in Systemic Lupus Erythematosus: Relationship with Clinical Features
Micaela Ana Cosatti¹, Sebastian Muñoz², Paula Alba³, Claudia Andrea Helling⁴, Susana Roverano⁵, Judith Sarano⁶, Samanta Malm- Green⁷, Anastasia Secco⁸, Maria Danielsen⁹, Danith Medina Bornachera¹⁰, Analia Alvarez¹¹, Alicia Eimon¹², Dora Pereira¹³ and Cecilia N. Pisoni¹⁴, ¹Section Rheumatology and Immunology, CEMIC, CABA, Argentina, ²Hospital Fernandez, CABA, Argentina, ³Hospital Córdoba, Cordoba, Argentina, ⁴URUGUAY 725, Omi, CABA, Argentina, ⁵Rheumatology Section, Hospital J. M. Cullen, Santa Fe, Argentina, ⁶Instituto de Investigaciones Médicas Alfredo Lanari, CABA, Argentina, ⁷Hospital Bernardino Rivadavia, CABA, Argentina, ⁸Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ⁹Rheumatology, Hospital Regional, Santiago del Estero, Argentina, ¹⁰Hospital Penna, CABA, Argentina, ¹¹Pedro Chutro 3380, Hospital Penna, CABA, Argentina, ¹²Soler 4149 - Palermo, CEMIC, CABA, Argentina, ¹³Hospital Ricardo Gutierrez, La Plata, La Plata, Argentina, ¹⁴Section of Rheumatology and Immunology, Centro de Educación, CEMIC, CABA, Argentina
Background/Purpose: To measure work productivity and the related risk factors in patients with systemic lupus erythematosus (SLE) from Argentina. Methods: Employment status of 171 consecutive SLE…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].